EMME HEALTH
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99270384
- Mark type
- Stylized text
- Filed
- 07 Jul 2025
- Published for opposition
- 17 Mar 2026
Goods and services
- Class 035 — Advertising and business services: Providing business intelligence services in the fields of medical devices, pharmaceuticals, and the life sciences; marketing consulting; consultation services, namely, creative and strategic consultation regarding development and production of marketing campaigns for others; assistance in business management and product commercialization; strategic business consulting using an AI platform based on health equity and access for the health care, public health, and life sciences industries; all of the foregoing excluding business consultation services in the field of regulatory compliance programs, namely, assessment and design of policies, procedures, forms, and training in conflicts of interest, anti-bribery and corruption, personal data privacy, and trademark compliance.
Owner
- mock5 design, inc., Lansdale, PA, US
- mock5 design, inc., Lansdale, PA, US
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Feb 2026 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 09 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 09 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 09 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 06 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Nov 2025 — NON-FINAL ACTION E-MAILED
- 24 Nov 2025 — NON-FINAL ACTION WRITTEN